Preclinical evaluation of KH631, a novel rAAV8 gene therapy product for neovascular age-related macular degeneration

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Jeffrey S. Heier, David M. Brown, Victor Chong et al. · Ophthalmology · 2012 · 2.5K citations

Medicine, Ophthalmology, Vision Science +16

AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

Jean Bennett, Manzar Ashtari, Jennifer Wellman et al. · Science Translational Medicine · 2012 · 391 citations · Full text

Medicine, Immunology, Ophthalmology +17

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton et al. · EMBO Molecular Medicine · 2016 · 359 citations · Full text

Medicine, Ophthalmology, Pharmacology +15

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · Retina · 2017 · 341 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +17

High-dose AAV gene therapy deaths

Nature Biotechnology · 2020 · 247 citations · Full text

Medicine, Genetics, Molecular Biology +7